Chemotherapy alone in the treatment of patients with early stage Hodgkin's disease

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Longo, D L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Early stages; Hodgkin's disease

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; LOMUSTINE; PREDNISONE; PROCARBAZINE; STREPTOZOCIN; VINBLASTINE SULFATE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; EARLY CANCER; HODGKIN DISEASE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL;

EID: 0029798737     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.S85     Document Type: Conference Paper

References (19)

1. Hoppe RT. Radiation therapy for Hodgkin's disease. Semin Oncol 1990; 17:704-15.
2. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270:1949-55.
3. Tucker MA, Coleman CN, Cox RS et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318:76-81.
4. Meadows AT, Obringer AC, Marrero O et al. Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 1989; 17:477-84.
5. Bookman MA, Longo DL. Concomitant illness in patients treated for Hodgkin's disease. Cancer Treat Rev 1986; 13: 77-111.
6. Leibenhaut MH, Hoppe RT, Efron B et al. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7:81-91.
7. Carde P, Hagenbeek A, Hayat M et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: The H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1993; 11:2258-72.
8. Anderson H, Crowther D, Deakin DP et al. A randomized study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-Year follow-up. Ann Oncol 1991; 2 (Suppl 2): 49-54.
9. Shore T, Nelson N, Weinerman B. A meta-analysis of stages I and II Hodgkin's disease. Cancer 1990; 65:1155-60.
10. Horning SJ, Hoppe RT, Hancock SL, Rosenberg SA. Vinblastine, bleomycin and methotrexate: An effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 1988; 6:1822-31.
11. Bates NP, Williams MV, Bessell EM et al. Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: A British National Lymphoma Investigation pilot study. J Clin Oncol 1994; 12:288-96.
12. Olweny CLM, Katongole-Mbidde E, Kiive C et al. Childhood Hodgkin's disease in Uganda: A 10-year experience. Cancer 1978; 42:789-92.
13. Ekert H, Waters KD, Smith PJ et al. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.J Clin Oncol 1988; 6:1845-50.
14. O'Dwyer PJ, Wiernik PH, Stewart MB, Slawson RG. Treatment of early stage Hodgkin's disease: A randomized trial of radiotherapy plus chemotherapy versus chemotherapy alone. In Cavalli F, Bonadonna G, Rozencweig M (eds): Malignant Lymphomas and Hodgkin's Disease: Experimental and Therapeutic Advances. Boston: Martinus Nijhoff 1985; 329-36.
15. Pavlovsky S, Maschio M, Santarelli MT et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. J Natl Cancer Inst 1988; 80: 1466-73.
16. Crowther D, Wagstaff J, Deakin D et al. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease. J Clin Oncol 1984; 2:892-7.
17. Longo DL, Glatstein E, Duffey PL et al. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J Clin Oncol 1991; 9:906-17.
18. Biti GP, Cimino G, Cartoni C et al. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight-year update of an Italian prospective randomized study. J Clin Oncol 1992; 10:378-82.
19. Roach M, Brophy N, Cox R et al. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. J Clin Oncol 1990; 8:623-9.